This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.
Get full access to this article
View all access options for this article.
References
1.
American Heart Association.Heart Disease and Stroke Statistics-2007 Update.Dallas, Tex: American Heart Association; 2007.
2.
GillespieE.L., ColemanC.I., SanderS.. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother.2005; 39: 1409–1415.
3.
DiDomenicoR.J., MassadM.G.Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg.2005; 79: 728–740.
4.
BakerW.L., WhiteC.M.Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother.2007; 41: 587–598.
5.
MathewJ.P., FontesM.L., TudorI.C.. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA.2004; 291: 1720–1729.
6.
JayamV.K.S., FlakerG.C., JonesJ.W.Atrial fibrillation after coronary bypass: etiology and pharmacologic prevention. Cardiovasc Surg.2002; 10: 351–358.
7.
ChungM.K.Cardiac surgery: postoperative arrhythmias. Crit Care Med.2000; 28(supp 10): N136–N144.
8.
MaiselW.H., RawnJ.D., StevensonW.G.Atrial fibrillation after cardiac surgery. Ann Intern Med.2001; 135: 1061–1073.
9.
MathewJ.P., ParksR., SavinoJ.S.. Atrial fibrillation following cardiac artery bypass graft surgery: predictors, outcomes and resource utilization. Multicenter study of Perioperative Ischemia Research Group. JAMA.1996; 276: 300–306.
DaoudE.G., StrickbergerA., ManK.C.. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med.1997; 337: 1785–1791.
12.
GiriS., WhiteC.M., DunnA.B.. Oral amiodarone for prevention of atrial fibrillation after open heart surgery: the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet.2001; 357: 830–886.
13.
RedleJ.D., KhuranaS., MarzanR.. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J.1999; 138: 144–150.
14.
MarasD., BoskovicS.D., PopovicZ.. Single-day loading dose of oral amiodarone for the prevention on new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J.2001; 141: e8.
15.
MitchellL.B., ExnerD.V., WyseD.G.. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA.2005; 294: 3093–3100.
16.
AndrewsT.C., ReimoldS.C., BerlinJ.A., AntmanE.M.Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis or randomized controlled trials. Circulation.1991; 84: III236–III244.
17.
AasboJ.D., LawrenceA.T., KrishnanK., KimM.H., TrohmanR.G.Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med.2005; 143: 327–336.
18.
MasonJ.W.Amiodarone. N Engl J Med.1987; 316: 455–466.
19.
ChowM.S.Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Ann Pharmacother.1996; 30: 637–643.
20.
RatzBravoA.E., DreweJ., SchliengerR.G., KrahenbuhlS., ParggerH., UmmerenhoferW.Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med.2005; 33: 128–134.
21.
HughesM., BinningA.Intravenous amiodarone in intensive care. Time for a reappraisal?Intensive Care Med.2000; 26: 1730–1739.
22.
CheungA.T., WeissS.J., SavinoS.J.. Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. Ann Thorac Surg.2003; 76: 535–541.
23.
PatelA.A., WhiteC.M., GillespieE.L., KlugerJ., ColemanC.I.Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm.2006; 68: 829–837.
24.
SombergJ.C., CaoW., CvetanovicI., RanadeV.Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (AmioAqueous) compared to Cordarone IV. Am J Ther.2005; 12: 9–16.
25.
ArankiS.F., ShawD.P., AdamsD.H.. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation.1996; 94: 390–397.
26.
ReddyP., RichersonM., Freeman-BoscoL., DunnA., WhiteC.M., ChowM.S.Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery. Am J Health Syst Pharm.1999; 56: 2211–2217.
27.
GillespieE.L., WhiteC.M., KlugerJ., Ran CourtJ.A., GallagherR., ColemanC.I.Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy.2006; 26: 499–504.
28.
BarnesB.J., KirklandE.A., HowardP.A.. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann Thorac Surg.2006; 82: 1332–1337.
29.
WhiteC.M., CaronM.F., KalusJ.S.. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II(AFIST II). Circulation.2003; 108(Suppl 2): II200–II206.
30.
BuckleyM.S., NolanP.E., SlackM.K., TisdaleJ.E., HillemanD.E., CopelandJ.G.Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy.2007; 27: 360–368.
31.
BarnesB.J., GrauerD.W., HowardP.A.. Effectiveness and tolerability of concomitant beta-blocker-amiodarone therapy to prevent postoperative atrial fibrillation after cardiac surgery [abstract]. Pharmacotherapy.2005; 25: 1439.
